Time Schedule
Monday, April 09 19:30-20:30 Opening Ceremony | 20:30-21:00 Keynote Speaker | 21:00-21:30 Discussion | 22:00 Dinner | Tuesday, April 10 07:00-08:00 Breakfast / Registration | 1st Session: Acute Coronary Syndrome (ACS): 08:00-09:15 | 08:00-08:25 Acute Coronary Syndrome Management: Current Challenges and Emerging Solutions. | 08:25-08:50 Dug Eluting Stent: An Update on Clinical Data. | 08:50-09:05 Antiplatelet Strategies in Acute Coronary Syndrome: Expanding Choices. | 09:15-09:30 Discussion | 09:30-09:40 Break | 2nd Session: Evolution of Antithrombotic Therapy Use in Acute Coronary Syndrome: 09:40-10:45 | 9:40-10:05 Anticoagulant in ACS and Beyond. | 10:05-10:30 Newer Antiplatelet: Confronting the Limitations of Antiplatelet Therapy. | 10:30-10:55 Risk of Bleeding: Balancing Risk and Benefit. | 10:55-11:10 Discussion | 11:10-11:20 Break | 3rd Session: Heart Failure (HF): 11:20-12:15 | 11:20-11:45 Heart Failure: Current Medical Therapy. | 11:45-12:10 Heart Rate as a Therapeutic Target in Heart Failure Patients. | 12:10-12:35 Devices and Technology in the Management of Heart Failure. | 12:35-12:50 Discussion | 12:50-14:00 Prayer Time, Lunch Break, Exhibition | 4th Session: Hypertension: 14:00-16:00 | 14:00-14:25 Update on Hypertension Management. | 14:25-14:50 JNC 8 (VIII): What is new going to be in the guidelines? | 14:50-15:15 Strategies for the Management of Resistant Hypertension. | 15:15-15:30 Discussion, Prayer Time | 5th Session: Ambulatory care in Cardiology: 15:30-16:45 | 15:30-15:55 Medication safety concerns in the cardiovascular patient. | 15:55-16:20 Lipid management: Optimizing Therapies Old and New. | 16:20-16:45 Primary prevention of cardiovascular disease: Tools and Strategies. | 16:45-17:00 Discussion | Wednesday, April 11 07:00-08:00 Breakfast / Registration | 1st Session: Atrial fibrillation (Afib): 08:00-09:15 | 08:00-08:25 Contemporary approach in Atrial Fibrillation Management. | 08:25-08:50 Antithrombotic Therapy in Afib: Defining the future of Oral Anticoagulant Therapy. | 08:50-09:15 Combined Atrial Fibrillation and Heart Failure: Challenges in Pharmacotherapy Management. | 09:15-09:30 Discussion | 09:30-09:40 Break | 2nd Session: End stage Heart Failure and Heart Transplant: 09:30-10:45 | 09:40-10:05 ICU Management of End Stage Heart Failure and Mechanical Circulatory Support Therapy. | 10:05-10:30 Heart Transplant: indication, selection, pre and post op care. | 10:30-10:55 Long Term Management of Heart Transplant and the Pharmacist Role. | 10:55-11:10 Discussion | 11:10-11:20 Break | 3rd Session: Venous Thromboembolism (VTE) Challenge and Valvular Heart Disease (VHD) Management: 11:00-12:15 | 11:20-11:45 VTE: Acute and Chronic Management. | 11:45-12:10 Contemporary Management of VHD in Various Medical Settings. | 12:10-12:35 Transcatheter Aortic Valve Implantation (TAVI): Highlight on Procedural and Pharmacotherapy Management Implications. | 12:35-12:50 Discussion | 12:50-14:00 Prayer Time, Lunch Break, Exhibition | 4th Session: Personalized Medicine in Cardiology: 14:00-16:00 | 14:00-14:25 Antiplatelet resistant / un-responsiveness: Genomic Markers and Advanced Testing. | 14:25-14:50 Tailored antiplatelet therapy: Pharmacogenomics or Dynamic Applications? | 14:50-15:15 Women cardiology: Differences in Diagnosis and Management. | 15:15-15:30 Discussion, Prayer | 5th Session: Pulmonary Hypertension: 15:30-16:45 | 15:30-15:55 Diagnosis and Treatment of Pulmonary Hypertension. | 15:55-16:20 Pulmonary Hypertension in ICU Setting. | 16:20-16:45 Perspectives on Pharmacoeconomic Appropriateness of Pulmonary Hypertension Medications. | 16:45-17:00 Discussion | 17:00-17:30: Closing Ceremony
Slider

The Saudi Pharmaceutical Society (SPS)

The Saudi Pharmaceutical Society (SPS) is the only scientific and professional organization representing pharmacists in the Kingdom of Saudi Arabia. The society was established in 1988 with a membership of more than 4000 pharmacists. The Board of the Society is elected every 3 years. SPS provides wide range of services for its members, including:

Continuing Education credits from both the Saudi Commission for Health Specialists (SCFHS) and the Accreditation Council of Pharmacy Education (ACPE). Saudi Pharmaceutical Journal (SPJ) a peer reviewed pharmaceutical journal with 4 issues per year. Newsletter (3 issues /year) The Pharmacists magazine (3 issues/year) Organizes an international meeting every 3 years Take initiatives supporting pharmacy issues Patient education materials Different interest groups (clubs) have been established within SPS, including:

Hospital pharmacy club Clinical pharmacy club Controlled medications club

For more information about SPS, please visit our website: www.sps-sa.net

Sponsors